Singapore and Silicon Valley-based biotech firm Engine Biosciences on Wednesday announced it has raised $43 million (S$57 million) in a Series A round led by US-based healthcare and technology investor Polaris Partners.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
